1. Home
  2. HLN

as of 08-07-2026 3:59pm EST

$10.04
+$0.01
+0.05%
Stocks Consumer Discretionary Package Goods/Cosmetics Nasdaq

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Founded: 2022 Country:
United Kingdom
United Kingdom
Employees: 24524 City: N/A
Market Cap: 44.5B IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 11.1M
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
1.94%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $8.65 - $11.28 Next Earning Date: 02-26-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 6.55% Revenue Growth (next year): 4.42%
P/E Ratio: 49.05 Index: N/A
Free Cash Flow: N/A FCF Growth: +12.72%

Share on Social Networks: